Time-dependent effects on survival in breast carcinoma -: Results of 20 years of follow-up from the Swedish two-county study

被引:66
作者
Warwick, J
Tabàr, L
Vitak, B
Duffy, SW
机构
[1] Canc Res UK, Dept Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England
[2] Falun Cent Hosp, Dept Mammog, Falun, Sweden
[3] Linkoping Univ Hosp, Dept Radiol, S-58185 Linkoping, Sweden
关键词
breast carcinoma; survival; Cox regression analysis; frailty; prognostic factors;
D O I
10.1002/cncr.20140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Tumor size, lymph node status, and histologic grade are reported to be important predictors of survival in the first 5 years after the diagnosis of invasive breast carcinoma. However, to the authors' knowledge, the effect of these factors in the longer term (> 10 years after diagnosis) is not yet clear. METHODS. it is now > 20 years since the Swedish Two-County Trial of breast carcinoma screening with mammography was instigated and long-term follow-up is now available to December 1998. In the current study, the authors analyzed the effects of tumor size, lymph node status, and tumor grade on survival to death from breast carcinoma using Cox regression and frailty models that allow the baseline hazard and/or effect of a covariate to vary with time. RESULTS. The effects of tumor size, lymph node status, and tumor grade were shown to progressively diminish with time from diagnosis. The Cox regression model with time-varying coefficients and a dampening parameter then was fitted to allow for the attenuation of prognostic effects; tumor size, lymph node status, and tumor grade were all found to be highly significant (P < 0.001). CONCLUSIONS. The results of the current study suggest that long-term survival in women with invasive breast carcinoma could be modelled satisfactorily using either frailty models or Cox regression models with time-varying coefficients. The results also suggest that the value of tumor grade, lymph node status, and tumor size at the time of diagnosis have a lasting influence on subsequent survival, albeit attenuated in later years. The long-term effects of these prognostic factors may explain the fact that the impact of mass screening programs on breast carcinoma mortality rates is still apparent many years later. Cancer 2004; 100: 1331- 6. (C) 2004 Arnerican Cancer Society.
引用
收藏
页码:1331 / 1336
页数:6
相关论文
共 19 条
  • [1] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    [J]. BRITISH JOURNAL OF CANCER, 1957, 11 (03) : 359 - &
  • [2] COLLETT K, 1988, BREAST CANC RES TREA, V48, P1
  • [3] COX DR, 1972, J R STAT SOC B, V34, P187
  • [4] BREAST SCREENING, PROGNOSTIC FACTORS AND SURVIVAL - RESULTS FROM THE SWEDISH 2 COUNTY STUDY
    DUFFY, SW
    TABAR, L
    FAGERBERG, G
    GAD, A
    GRONTOFT, O
    SOUTH, MC
    DAY, NE
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (06) : 1133 - 1138
  • [5] A PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER
    HAYBITTLE, JL
    BLAMEY, RW
    ELSTON, CW
    JOHNSON, J
    DOYLE, PJ
    CAMPBELL, FC
    NICHOLSON, RI
    GRIFFITHS, K
    [J]. BRITISH JOURNAL OF CANCER, 1982, 45 (03) : 361 - 366
  • [6] p53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support
    Hensel, M
    Schneeweiss, A
    Sinn, HP
    Egerer, G
    Solomayer, E
    Haas, R
    Bastert, G
    Ho, AD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (03) : 290 - 296
  • [7] Jenkins S.P., 1997, STATA TECHNICAL B, V39, P22
  • [8] LONG-TERM SURVIVAL OF PATIENTS WITH BREAST-CANCER - STUDY OF THE CURABILITY OF THE DISEASE
    LANGLANDS, AO
    POCOCK, SJ
    KERR, GR
    GORE, SM
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6200) : 1247 - 1251
  • [9] BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF C-ERB-B2 AND INT-2 AMPLIFICATION COMPARED WITH DNA-PLOIDY, S-PHASE FRACTION, AND CONVENTIONAL CLINICOPATHOLOGICAL FEATURES
    LONN, U
    LONN, S
    NILSSON, B
    STENKVIST, B
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (03) : 237 - 245
  • [10] S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
    Malmström, P
    Bendahl, PO
    Boiesen, P
    Brünner, N
    Idvall, I
    Fernö, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 2010 - 2019